Evaluation of hyperglycaemic response to anti-emetic dose of dexamethasone in diabetic patients undergoing cholecystectomy

Abstract

Background: To evaluate hyperglycaemic response to an anti-emetic dose of dexamethasone in diabetic subjects undergoing Cholecystectomy surgery. Materials and Methods: A prospective study was conducted, over 120 ASA I and II, aged 16-60 years patients posted for Cholecystectomy under General Anaesthesia for a period of October 2021 to October 2022. Prior to the anaesthetic induction, diabetic and non-diabetic patients were randomly distributed by numbers generated computationally in two groups: Group A, 60 diabetic patients received 8 mg dexamethasone. Group B, 60 non-diabetic patients received 8 mg dexamethasone. Data were analysed using Statistical Package for Social Sciences, version 23 (SPSS Inc., Chicago, IL). Student t-test was used for group comparison. A p-value of